Aviptadil Acetate NEW
| Price | $84 | $178 | $289 |
| Package | 1mg | 5mg | 10mg |
| Supply Ability: | 10g |
| Update Time: | 2026-06-02 |
Product Details
| Product Name: Aviptadil Acetate | CAS No.: 1444827-29-5 |
| Purity: 100.00% | Supply Ability: 10g |
| Release date: 2026/06/02 |
Product Introduction
Bioactivity
| Name | Aviptadil Acetate |
| Description | Aviptadil Acetate (Vasoactive Intestinal Peptide acetate salt) induces pulmonary vasodilation and inhibits the proliferation of vascular SMCs and platelet aggregation. Avitadil acetate can be used for research on pulmonary fibrosis, pulmonary hypertension (PAH), and respiratory failure caused by SARS-CoV-2. |
| In vitro | Aviptadil acetate inhibits the basal proliferation of pulmonary arterial smooth muscle cells (PASMC) and the mobilization of intracellular free calcium concentration in these cells in a dose-dependent manner[2]. |
| In vivo | Inhaled vasoactive intestinal peptide(Aviptadil acetate ) as a local therapy to reduce the alveolar inflammation found in patients with immune checkpoint inhibitor pneumonitis[1]. |
| Storage | Keep away from moisture Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+90% Saline : 10 mg/mL (2.95 mM), Solution. DMSO : 122.5 mg/mL (36.18 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 3.3 mg/mL (0.97 mM), Sonication is recommended. |
| Keywords | Vasoactive Intestinal Peptide acetate salt (human, rat, mouse, rabbit, canine, porcine) | Vasoactive Intestinal Peptide Acetate | SARS-CoV-2 | SARS-CoV | SARSCoV | SARS coronavirus | Sarcoidosis | Sarcoid | Respiratory Failure | Respiratory Distress Syndrome | Pulmonary Fibrosis | Lung Injury | Inhibitor | inhibit | Corona Virus | Bronchospasm | Aviptadil Acetate | Aviptadil | ARDS | ALI | ACE |
| Inhibitors Related | Losartan potassium | Molnupiravir | Silymarin | Hydroxychloroquine | Ritonavir | Chloroquine phosphate | α-Cyclodextrin | Sacubitril/Valsartan | Benzyl benzoate | Dexamethasone | Diisononyl phthalate | Captopril |
| Related Compound Libraries | Peptide Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP2Y
|
Forest chemical technology
|
2026-07-10 | ||
|
VIP6Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2026-07-10 | ||
|
VIP2Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2026-06-30 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY